# DAPTOMYCIN
> **ANDA206005** · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2016-06-15
## Drug
- **FDA Application Number:** ANDA206005
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** XELLIA PHARMS APS
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2016-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206005)
---
*MORVS · CC0 1.0*